Cover Image
Market Research Report

Global Rice Protein Based Infant Formula Market: Industry Trends and Forecast to 2026

Published by Data Bridge Market Research Private Limited Product code 904426
Published Content info 305 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Rice Protein Based Infant Formula Market: Industry Trends and Forecast to 2026
Published: July 1, 2019 Content info: 305 Pages
Description

Global rice protein based infant formula market is projected to register a substantial CAGR of 5.9% in the forecast period of 2019 to 2026. The new market report contains data for thehistoric year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026

Market Segmentation

By Type (Formulated, Unformulated), Product Type (Standard Formula, Toddler Formula, Follow-On Formula, Special Formula), Form (Non-GMO, GMO), Infant Age (6-12 Months, 0-6 Months, 1-3 Years), Distribution Channel (Store-Based Retailer, Non-Store Retailer), Geography (Asia-Pacific, Europe, North America, South America, Middle East & Africa)

Some of the major factors contributing to the growth of the global rice protein based infant formula market:

  • Increasing number of birth rate
  • Rising number of children who are allergic to cow milk

Market Players:

The key market players for global rice protein based infant formula market are listed below:

  • Nucitec SA de CV
  • La Mandorle
  • Laboratorios Ordesa
  • Kate Farms
  • Bayer AG
  • Lactalis International
  • BIOLAB PHARMA
  • Novalac
Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET POSITION GRID
  • 2.8 DBMR VENDOR SHARE ANALYSIS
  • 2.9 MULTIVARIATE MODELING
  • 2.10 PRODUCTS LIFELINE CURVE
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 RISING POPULATION OF WORKING MOTHERS
    • 3.1.2 GROWING INFANT POPULATION
    • 3.1.3 INCREASING CASES OF BREAST CANCER
    • 3.1.4 RICE PROTEIN BASED INFANT FORMULA IS WIDELY ACCEPTED AS NON-ALLERGIC PRODUCT
  • 3.2 RESTRAINT
    • 3.2.1 STRINGENT REGULATION
  • 3.3 OPPORTUNITIES
    • 3.3.1 GROWING ECONOMIES AND DISPOSABLE INCOME IN EMERGING REGIONS
    • 3.3.2 INCREASING AWARENESS REGARDING IMPORTANCE OF NUTRITION FOR INFANTS
  • 3.4 CHALLENGES
    • 3.4.1 HIGH CONTENT OF TOXIC CHEMICALS IN RICE PROTEIN BASED INFANT FORMULA
    • 3.4.2 IMPROPER PACKAGING OF BABY FOOD

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY PRODUCT TYPE

  • 6.1 OVERVIEW
  • 6.2 FOLLOW-ON FORMULA
  • 6.3 TODDLER FORMULA
  • 6.4 STANDARD FORMULA
  • 6.5 SPECIAL FORMULA

7 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY TYPE

  • 7.1 OVERVIEW
  • 7.2 UNFORMULATED
  • 7.3 FORMULATED
    • 7.3.1 VEGETABLES
    • 7.3.2 FRUITS
    • 7.3.3 CEREAL

8 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY FORM

  • 8.1 OVERVIEW
  • 8.2 NON-GMO
  • 8.3 GMO

9 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY INFANT AGE

  • 9.1 OVERVIEW
  • 9.2 6-12 MONTHS
  • 9.3 1-3 YEARS
  • 9.4 0-6 MONTHS

10 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY DISTRIBUTION CHANNEL

  • 10.1 OVERVIEW
  • 10.2 STORE-BASED RETAILER
    • 10.2.1 CONVENIENCE STORES
    • 10.2.2 SUPERMARKETS/HYPERMARKETS
    • 10.2.3 SPECIALTY STORES
    • 10.2.4 GROCERY STORES
    • 10.2.5 WHOLESALERS
  • 10.3 NON-STORE RETAILER
    • 10.3.1 ONLINE
    • 10.3.2 VENDING

11 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY GEOGRAPHY

  • 11.1 OVERVIEW
  • 11.2 NORTH AMERICA
    • 11.2.1 U.S.
    • 11.2.2 CANADA
    • 11.2.3 MEXICO
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 FRANCE
    • 11.3.3 U.K.
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 NETHERLANDS
    • 11.3.7 POLAND
    • 11.3.8 SWEDEN
    • 11.3.9 SWITZERLAND
    • 11.3.10 BELGIUM
    • 11.3.11 DENMARK
    • 11.3.12 RUSSIA
    • 11.3.13 TURKEY
    • 11.3.14 REST OF EUROPE
  • 11.4 ASIA-PACIFIC
    • 11.4.1 CHINA
    • 11.4.2 JAPAN
    • 11.4.3 INDIA
    • 11.4.4 SOUTH KOREA
    • 11.4.5 AUSTRALIA
    • 11.4.6 SINGAPORE
    • 11.4.7 THAILAND
    • 11.4.8 INDONESIA
    • 11.4.9 MALAYSIA
    • 11.4.10 NEW ZEALAND
    • 11.4.11 PHILIPPINES
    • 11.4.12 VIETNAM
    • 11.4.13 REST OF ASIA-PACIFIC
  • 11.5 SOUTH AMERICA
    • 11.5.1 BRAZIL
    • 11.5.2 ARGENTINA
    • 11.5.3 REST OF SOUTH AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 SOUTH AFRICA
    • 11.6.2 SAUDI ARABIA
    • 11.6.3 UAE
    • 11.6.4 KUWAIT
    • 11.6.5 OMAN
    • 11.6.6 QATAR
    • 11.6.7 REST OF MIDDLE EAST & AFRICA

12 SWOT & DBMR ANALYSIS

  • 12.1 SWOT ANALYSIS
  • 12.2 DATA BRIDGE MARKET RESEARCH ANALYSIS

13 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, COMPANY LANDSCAPE

  • 13.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 13.3 COMPANY SHARE ANALYSIS: EUROPE
  • 13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
  • 13.5 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

14 COMPANY PROFILE

  • 14.1 LACTALIS INTERNATIONAL
    • 14.1.1 COMPANY SNAPSHOT
    • 14.1.2 COMPANY SHARE ANALYSIS
    • 14.1.3 PRODUCT PORTFOLIO
    • 14.1.4 RECENT DEVELOPMENTS
  • 14.2 NOVALAC
    • 14.2.1 COMPANY SNAPSHOT
    • 14.2.2 COMPANY SHARE ANALYSIS
    • 14.2.3 PRODUCT PORTFOLIO
    • 14.2.4 RECENT DEVELOPMENT
  • 14.3 BAYER AG
    • 14.3.1 COMPANY SNAPSHOT
    • 14.3.2 REVENUE ANALYSIS
    • 14.3.3 COMPANY SHARE ANALYSIS
    • 14.3.4 PRODUCT PORTFOLIO
    • 14.3.5 RECENT DEVELOPMENT
  • 14.4 LABORATORIOS ORDESA
    • 14.4.1 COMPANY SNAPSHOT
    • 14.4.2 COMPANY SHARE ANALYSIS
    • 14.4.3 PRODUCT PORTFOLIO
    • 14.4.4 RECENT DEVELOPMENT
  • 14.5 BIOLAB PHARMA
    • 14.5.1 COMPANY SNAPSHOT
    • 14.5.2 PRODUCT PORTFOLIO
    • 14.5.3 RECENT DEVELOPMENT
  • 14.6 KATE FARMS
    • 14.6.1 COMPANY SNAPSHOT
    • 14.6.2 PRODUCT PORTFOLIO
    • 14.6.3 RECENT DEVELOPMENT
  • 14.7 LA MANDORLE
    • 14.7.1 COMPANY SNAPSHOT
    • 14.7.2 PRODUCT PORTFOLIO
    • 14.7.3 RECENT DEVELOPMENT
  • 14.8 NUCITEC SA DE CV
    • 14.8.1 COMPANY SNAPSHOT
    • 14.8.2 PRODUCT PORTFOLIO
    • 14.8.3 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 CONCLUSION

17 RELATED REPORTS

LIST OF FIGURES

  • FIGURE 1 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: DATA VALIDATION MODEL
  • FIGURE 3 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 9 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGES OF GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET
  • FIGURE 10 PERCENTAGE OF WORKING MOTHERS HAVING YOUNGEST CHILD OF 3 OR 4 YEARS OLD (2010 -2017)
  • FIGURE 11 ESTIMATED NUMBER OF INCIDENT CASES OF BREAST CANCER IN FEMALES, 2018
  • FIGURE 12 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: SEGMENTATION
  • FIGURE 13 ASIA-PACIFIC IS ANTICIPATED TO DOMINATE THE RICE PROTEIN BASED INFANT FORMULA MARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 14 GROWING INFANT POPULATION AND RISING POPULATION OF WORKING MOTHERS ARE EXPECTED TO DRIVE THE GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 15 FOLLOW-ON FORMULA IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET IN 2019 & 2026
  • FIGURE 16 ASIA-PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 17 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE, 2018
  • FIGURE 18 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY TYPE, 2018
  • FIGURE 19 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY FORM, 2018
  • FIGURE 20 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY INFANT AGE, 2018
  • FIGURE 21 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: SNAPSHOT (2018)
  • FIGURE 22 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY GEOGRAPHY (2018)
  • FIGURE 23 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY GEOGRAPHY (2019 & 2026)
  • FIGURE 24 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY GEOGRAPHY (2018 & 2026)
  • FIGURE 25 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 26 NORTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: SNAPSHOT (2018)
  • FIGURE 27 NORTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018)
  • FIGURE 28 NORTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 29 NORTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 30 NORTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 31 EUROPE RICE PROTEIN BASED INFANT FORMULA MARKET: SNAPSHOT (2018)
  • FIGURE 32 EUROPE RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018)
  • FIGURE 33 EUROPE RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 34 EUROPE RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 35 EUROPE RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 36 ASIA-PACIFIC RICE PROTEIN BASED INFANT FORMULA MARKET: SNAPSHOT (2018)
  • FIGURE 37 ASIA-PACIFIC RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018)
  • FIGURE 38 ASIA-PACIFIC RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 39 ASIA-PACIFIC RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 40 ASIA-PACIFIC RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 41 SOUTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: SNAPSHOT (2018)
  • FIGURE 42 SOUTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018)
  • FIGURE 43 SOUTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 44 SOUTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 45 SOUTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 46 MIDDLE EAST & AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: SNAPSHOT (2018)
  • FIGURE 47 MIDDLE EAST & AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018)
  • FIGURE 48 MIDDLE EAST & AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 49 MIDDLE EAST & AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 50 MIDDLE EAST & AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 51 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 52 NORTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 53 EUROPE RICE PROTEIN BASED INFANT FORMULA MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 54 ASIA-PACIFIC RICE PROTEIN BASED INFANT FORMULA MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 55 MIDDLE EAST & AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: COMPANY SHARE 2018 (%)
Back to Top